Collagen V is a Dominant Regulator of Collagen Fibrillogenesis: Dysfunctional Regulation of Structure and Function in a Corneal-stroma-specific Col5a1-null Mouse Model

Overview

Journal J Cell Sci

Specialty Cell Biology

Date 2011 Dec 14

PMID 22159420

Citations 88

Authors

Mei Sun

Shoujun Chen

Sheila M Adams

Jane B Florer

Hongshan Liu

Winston W-Y Kao

Richard J Wenstrup

David E Birk

Affiliations

Soon will be listed here.

Abstract

Collagen V is a regulatory fibril-forming collagen that forms heterotypic fibrils with collagen I. Deletion of collagen V in the mouse is associated with a lack of fibril assembly in the embryonic mesenchyme, with a resultant lethal phenotype. The current work elucidates the regulatory roles of collagen V during development and growth of tissues. A conditional mouse model with a mutation in Col5a1 was developed using a Cre-loxP approach. Col5a1 was ablated in Col5a1(flox/flox) mice using a cornea stroma-specific Kera-Cre driver mouse to produce a bitransgenic Col5a1(Δst/Δst) line that is null for collagen V. This permits analyses of the corneal stroma, a widely used model for studies of collagen V. The collagen-V-knockout stroma demonstrated severe dysfunctional regulation of fibrillogenesis. Fibril diameters were significantly increased, with an abnormal, heterogeneous distribution; fibril structure was abnormal, fibril number was decreased and lamellae were disorganized with decreased stroma thickness. The phenotype was more severe in the anterior versus posterior stroma. Opacity was demonstrated throughout the Col5a1(Δst/Δst) stroma, with significantly increased haze intensity compared with control mice. These data indicate central regulatory roles for collagen V in fibril and matrix assembly during tissue development, with dysfunctional regulation resulting in a functional loss of transparency.

Citing Articles

Whole-genome sequencing identifies novel loci for keratoconus and facilitates risk stratification in a Han Chinese population.

Yao Y, Li X, Wu L, Zhang J, Gui Y, Yu X Eye Vis (Lond). 2025; 12(1):5.

PMID: 39762938 PMC: 11706019. DOI: 10.1186/s40662-024-00421-1.

Identification and validation of the diagnostic biomarker MFAP5 for CAVD with type 2 diabetes by bioinformatics analysis.

Shen Q, Fan L, Jiang C, Yao D, Qian X, Tong F Front Immunol. 2025; 15:1506663.

PMID: 39749331 PMC: 11693595. DOI: 10.3389/fimmu.2024.1506663.

True-bone-ceramics / type I collagen scaffolds for repairing osteochondral defect.

Jiang Y, Li T, Lou Y, Liu B, Liu Y, Li T J Mater Sci Mater Med. 2024; 36(1):1.

PMID: 39738976 PMC: 11685269. DOI: 10.1007/s10856-024-06852-5.

TriHex 2.0-Advancing Skin Health Science and the TriHex Technology.

Widgerow A, Ziegler M, Shafiq F J Cosmet Dermatol. 2024; 24(2):e16690.

PMID: 39660586 PMC: 11845939. DOI: 10.1111/jocd.16690.

Identification of novel nutrient sensitive human yolk sac functions required for embryogenesis.

White M, Arif-Pardy J, Bloise E, Connor K Sci Rep. 2024; 14(1):29734.

PMID: 39613845 PMC: 11607434. DOI: 10.1038/s41598-024-81061-2.

References

Malfait F, Wenstrup R, De Paepe A . Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet Med. 2010; 12(10):597-605. DOI: 10.1097/GIM.0b013e3181eed412. View

Colige A, Nuytinck L, Hausser I, van Essen A, Thiry M, Herens C . Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 gene. J Invest Dermatol. 2004; 123(4):656-63. DOI: 10.1111/j.0022-202X.2004.23406.x. View

Mao J, Taylor G, Dean W, Wagner D, Afzal V, Lotz J . Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat Genet. 2002; 30(4):421-5. DOI: 10.1038/ng850. View

Chakravarti S, Magnuson T, Lass J, Jepsen K, Lamantia C, Carroll H . Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol. 1998; 141(5):1277-86. PMC: 2137175. DOI: 10.1083/jcb.141.5.1277. View

Ezura Y, Chakravarti S, Oldberg A, Chervoneva I, Birk D . Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J Cell Biol. 2000; 151(4):779-88. PMC: 2169450. DOI: 10.1083/jcb.151.4.779. View

Birk D, Fitch J, Babiarz J, Doane K, Linsenmayer T . Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J Cell Sci. 1990; 95 ( Pt 4):649-57. DOI: 10.1242/jcs.95.4.649. View

Wenstrup R, Florer J, Willing M, Giunta C, Steinmann B, Young F . COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. Am J Hum Genet. 2000; 66(6):1766-76. PMC: 1378044. DOI: 10.1086/302930. View

Nicholls A, Oliver J, McCarron S, Harrison J, Greenspan D, Pope F . An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome. J Med Genet. 1996; 33(11):940-6. PMC: 1050789. DOI: 10.1136/jmg.33.11.940. View

Marchant J, Hahn R, Linsenmayer T, Birk D . Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal-specific fibril morphology. J Cell Biol. 1996; 135(5):1415-26. PMC: 2121086. DOI: 10.1083/jcb.135.5.1415. View

10.

Burrows N, Nicholls A, Yates J, Richards A, Pope F . Genetic linkage to the collagen alpha 1 (V) gene (COL5A1) in two British Ehlers-Danlos syndrome families with variable type I and II phenotypes. Clin Exp Dermatol. 1997; 22(4):174-6. View

11.

Bristow J, Carey W, Egging D, Schalkwijk J . Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet. 2005; 139C(1):24-30. DOI: 10.1002/ajmg.c.30071. View

12.

Birk D, Trelstad R . Extracellular compartments in matrix morphogenesis: collagen fibril, bundle, and lamellar formation by corneal fibroblasts. J Cell Biol. 1984; 99(6):2024-33. PMC: 2113579. DOI: 10.1083/jcb.99.6.2024. View

13.

Vogel A, Holbrook K, Steinmann B, GITZELMANN R, Byers P . Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome. Lab Invest. 1979; 40(2):201-6. View

14.

Hausser I, Anton-Lamprecht I . Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I-IV as a means of diagnostics and classification. Hum Genet. 1994; 93(4):394-407. DOI: 10.1007/BF00201664. View

15.

Bredrup C, Knappskog P, Majewski J, Rodahl E, Boman H . Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Invest Ophthalmol Vis Sci. 2005; 46(2):420-6. DOI: 10.1167/iovs.04-0804. View

16.

Bouma P, Cabral W, Cole W, Marini J . COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of alpha 1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II. J Biol Chem. 2001; 276(16):13356-64. DOI: 10.1074/jbc.M011742200. View

17.

De Paepe A, Nuytinck L, Hausser I, Anton-Lamprecht I, Naeyaert J . Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II. Am J Hum Genet. 1997; 60(3):547-54. PMC: 1712501. View

18.

Liu H, Zhang J, Liu C, Wang I, Sieber M, Chang J . Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice. PLoS One. 2010; 5(5):e10707. PMC: 2873411. DOI: 10.1371/journal.pone.0010707. View

19.

Birk D . Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron. 2000; 32(3):223-37. DOI: 10.1016/s0968-4328(00)00043-3. View

20.

Wenstrup R, Florer J, Davidson J, Phillips C, Pfeiffer B, Menezes D . Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages. J Biol Chem. 2006; 281(18):12888-95. DOI: 10.1074/jbc.M511528200. View